Greater adherence and persistence with dulaglutide compared to injectable semaglutide at 6-and 12-months follow-up in US real-world data

被引：0
|
作者：
Mody, R. [1 ]
Manjelievskaia, J. [2 ]
Yu, M. [1 ]
Marchlewicz, E. H. [2 ]
Malik, R. [1 ]
Zimmerman, N. M. [2 ]
Irwin, D. E. [2 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] IBM Watson Hlth, Cambridge, MA USA
来源：
DIABETOLOGIA | 2021年 / 64卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
449
引用
收藏
页码：232 / 232
页数：1
相关论文
共 34 条
  • [1] Greater Adherence and Persistence with Dulaglutide Compared with Semaglutide at 6-and 12-Months Follow-up in US Real-World Data
    Mody, Reema
    Manjelievskaia, Janna
    Yu, Maria
    Marchlewicz, Elizabeth H.
    Malik, Raleigh
    Zimmerman, Nicole
    Irwin, Debra E.
    DIABETES, 2021, 70
  • [2] Higher adherence and persistence for dulaglutide compared to oral semaglutide at 6-months follow-up with US real-world data
    Paczkowski, R.
    Hoog, M. M.
    Peleshok, J.
    Yu, M.
    Huang, A.
    Limone, B.
    Manjelievskaia, J.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S297 - S298
  • [3] Higher Adherence and Persistence for Dulaglutide Compared with Oral Semaglutide at Six-Months Follow-Up with US Real-World Data
    Paczkowski, Rosirene
    Hoog, Meredith
    Peleshok, Jennifer
    Yu, Maria
    Ahong Huang
    Limone, Brendan
    Manjelievskaia, Janna
    DIABETES, 2022, 71
  • [4] Greater Adherence and Persistence with Injectable Dulaglutide Compared with Injectable Semaglutide at 1-Year Follow-up: Data from US Clinical Practice
    Mody, Reema
    Manjelievskaia, Janna
    Marchlewicz, Elizabeth H.
    Malik, Raleigh E.
    Zimmerman, Nicole M.
    Irwin, Debra E.
    Yu, Maria
    CLINICAL THERAPEUTICS, 2022, 44 (04) : 537 - +
  • [5] Dulaglutide Has Higher Adherence and Persistence than Semaglutide and Exenatide QW: 6-Month Follow-Up from US Real-World Data
    Mody, Reema
    Yu, Maria
    Nepal, Bal K.
    Konig, Manige
    Grabner, Michael
    DIABETES, 2020, 69
  • [6] Comparison of Adherence and Persistence between Oral Semaglutide and Once-Weekly Semaglutide Injection at 12-Month Follow-up in Japanese Real-World Data
    Horii, Takeshi
    Masudo, Chikako
    Mihara, Kiyoshi
    DIABETES, 2024, 73
  • [7] Dulaglutide has higher adherence and persistence than liraglutide and exenatide QW: 1-year follow-up from US real-world data
    Lando, L. Fernandez
    Mody, R.
    Huang, Q.
    Yu, M.
    Zhao, R.
    Patel, H.
    Grabner, M.
    DIABETOLOGIA, 2018, 61 : S372 - S372
  • [8] Adherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12 month follow-up: Japanese real-world data
    Horii, Takeshi
    Masudo, Chikako
    Takayanagi, Yui
    Oikawa, Yoichi
    Shimada, Akira
    Mihara, Kiyoshi
    JOURNAL OF DIABETES INVESTIGATION, 2024, 15 (11) : 1578 - 1584
  • [9] Adherence and persistence among patients with type 2 diabetes initiating dulaglutide compared with semaglutide and exenatideBCise: 6-month follow-up fromUS real-worlddata
    Mody, Reema
    Yu, Maria
    Nepal, Bal
    Konig, Manige
    Grabner, Michael
    DIABETES OBESITY & METABOLISM, 2021, 23 (01): : 106 - 115
  • [10] Adherence and Persistence Among Patients with Parkinson's disease (PD) Initiating Istradefylline: 12-Month Follow-Up from US Real-World Data
    Joseph, R.
    Qian, J.
    Cummings, H.
    Chen, Y.
    Tewari, S.
    Soileau, M.
    MOVEMENT DISORDERS, 2024, 39 : S376 - S376
1234